Akira Endo

Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study

Andrew Clark, Mark Jit, Charlotte Warren‐Gash et al. · The Lancet Global Health · 2020 · 1.2K citations · Full text

Veterinary Medicine, Infectious Diseases, Population Health Sciences +17

Effects of non-pharmaceutical interventions on COVID-19 cases, deaths, and demand for hospital services in the UK: a modelling study

Nicholas G. Davies, Adam J. Kucharski, Rosalind M. Eggo et al. · The Lancet Public Health · 2020 · 975 citations · Full text

Medicine, Health Policy, Infectious Disease Control +17

Effectiveness of isolation, testing, contact tracing, and physical distancing on reducing transmission of SARS-CoV-2 in different settings: a mathematical modelling study

Adam J. Kucharski, Petra Klepac, Andrew J. K. Conlan et al. · The Lancet Infectious Diseases · 2020 · 958 citations · Full text

Public Health, Infectious Disease Control, Infectious Diseases +6

ML-236A, ML-236B, and ML-236C, new inhibitors of cholesterogensis produced by Penicillium citrinum.

Akira Endo, Masao Kuroda, Yoshio Tsujita · The Journal of Antibiotics · 1976 · 954 citations · Full text

Life Sciences, Microbiology, Drug Discovery +2

The discovery and development of HMG-CoA reductase inhibitors.

Akira Endo · Journal of Lipid Research · 1992 · 840 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +11